Fabbio Patrick — SEC Form 4 filings
SEC reporting owner CIK 1658859. 9 Form 4 filings on record with FilingPulse; latest filed 2026-04-03.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-23 to 2026-04-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | Chief Financial Officer | 7 | — | — | 9 |
| BeyondSpring Inc. (BYSI) | Director | 2 | — | — | 2 |
Form 4 filings — Fabbio Patrick
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-03 | 4 | BeyondSpring Inc. (BYSI) | Grant/award (A): 22,165 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | Protara Therapeutics, Inc. (TARA) | Tax withholding (F): 3,261 @ $6.67 | EDGAR |
| 2026-01-22 | 4 | Protara Therapeutics, Inc. (TARA) | Tax withholding (F): 3,063 @ $5.60 | EDGAR |
| 2026-01-21 | 4 | Protara Therapeutics, Inc. (TARA) | Grant/award (A): 28,000 @ $0 · Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2025-04-23 | 4 | BeyondSpring Inc. (BYSI) | Grant/award (A): 23,793 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4/A | Protara Therapeutics, Inc. (TARA) | Holdings only — no transactions reported | EDGAR |
| 2025-01-28 | 4 | Protara Therapeutics, Inc. (TARA) | Grant/award (A): 23,500 @ $0 · Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | Protara Therapeutics, Inc. (TARA) | Tax withholding (F): 3,061 @ $4.76 | EDGAR |
| 2024-01-23 | 4 | Protara Therapeutics, Inc. (TARA) | Grant/award (A): 22,000 @ $0 · Grant/award (A): 131,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1658859 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →